Trade Summary

5 days ago, venBio Global Strategic Fund IV, L.P., serving as 10% owner Owner at Attovia Therapeutics, Inc. (ATTO), purchased 382,352 shares at $17.00 per share, for a total transaction value of $6,499,984.00. Following this transaction, venBio Global Strategic Fund IV, L.P. now holds 4,181,367 shares of ATTO.

This purchase represents a 10.06% increase in venBio Global Strategic Fund IV, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 4:12 PM ET, 4 days after the trade was made.

Attovia Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.